The broad-spectrum antiinfective drug artesunate interferes with the canonical nuclear factor kappa B (NF-κB) pathway by targeting RelA/p65
Authors
Keywords
Human cytomegalovirus, Artesunate and chemical derivatives, Broad antiviral activity, Increase of antiviral efficacy, Binding of artesunate to NF-κB RelA/p65, Interference with NF-κB signaling pathways
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now